<DOC>
	<DOC>NCT02813551</DOC>
	<brief_summary>Currently there is no intervention to prevent persistent postpartum hypertension in preeclamptic women. Physiologically, the use of a pharmacokinetically predictable loop-diuretic is a reasonable intervention to increase elimination of extra fluid accumulated secondary to preeclampsia.The purpose of this study is to assess if Torsemide reduces the incidence of persistent postpartum hypertension in preeclamptic women.</brief_summary>
	<brief_title>ToRsemide for pOstpartum HYpertension</brief_title>
	<detailed_description />
	<mesh_term>Hypertension</mesh_term>
	<mesh_term>Pre-Eclampsia</mesh_term>
	<mesh_term>Torsemide</mesh_term>
	<criteria>Postpartum women at â‰¥ 18 years of age Antepartum/intrapartum or within 24 hours postpartum diagnosis of either: Preeclampsia Preeclampsia with severe features Preeclampsia superimposed to chronic hypertension Chronic hypertension without superimposed preeclampsia Gestational hypertension Urine output &lt; 30 cc/h at time of randomization Heart failure or pulmonary edema Hypersensitivity to Torsemide or sulfonylureas Hypokalemia (serum potassium &lt; 3 mEq/L) Preexisting diuretic use within 24 hours prior to randomization</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2016</verification_date>
	<keyword>Preeclampsia, puerperium</keyword>
</DOC>